Repeated topical application of TGF-β3 reduced the cycling of buccal epithelium and reduced white blood cell count after 3 h. Topical TGF-β3 treatment before chemotherapy reduced the severity of oral mucositis, reduced weight loss, and improved survival. Here, TGFB3 is linked to oral mucositis.